Monday, 5 August 2013

New Release: Asia Pacific Renewable Energy Policy Handbook 2013

Asia-Pacific Renewable Energy Policy Handbook 2013” is the latest policy report from GlobalData, the industry analysis specialists that offer comprehensive information on major policies governing renewable energy market in the region.


The report presents an in-depth analysis of the renewable energy policies across the major countries in Asia-Pacific namely Australia, China, India, Japan, South Korea, Thailand, New Zealand, Vietnam and Taiwan. The report provides the current and future renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of their renewable energy industry. The report also provides major technology specific policies and incentives provided in each of these countries. The report also provides insights to major policy initiatives for the market development of renewable energy sources such as wind, solar, geothermal, biopower and biofuels. 

The report is built using data and information sourced from industry associations, government websites and statutory bodies. The information is also sourced through other secondary research sources such as industry and trade magazines.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172476


Scope

  • The report covers policy measures and incentives used by the major countries in Asia-Pacific to promote renewable energy.
  • The report details promotional measures in different countries both for the overall renewable energy industry and for specific renewable energy technologies namely solar, wind, geothermal, hydro and bioenergy.
  • The report also highlights the differences and focus of the renewable energy policy frameworks in different countries in Asia-Pacific.
  • The report provides a platform for comparison of various renewable energy policies across countries. Major countries include Australia, China, India, Japan, South Korea, Thailand, New Zealand, Vietnam and Taiwan.


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948


Finite Element Analysis Market in Thailand Singapore, Vietnam, Philippines, Malaysia, Indonesia 2012-2016

Finite Element Analysis (FEA) market in Thailand to grow at a high rate over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce the overall product development cost. The FEA market in Thailand has also been witnessing the development of collaborative FEA solutions. However, easy availability of open-source FEA software could pose a challenge to the growth of this market.


FEA Market in Thailand 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the FEA market in Thailand landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key questions answered in this report:

  • What will the market size be in 2016 and at what will be the growth rate?
  • What are key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?


TABLE OF CONTENT

1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Product Offerings


4. Market Landscape
4.1. Market Structure
4.2. Market Size and Forecast
4.3. Comparative Study
4.4. End-user Segmentation
4.5. Five Force Analysis

5. Vendor Landscape

6. Buying Criteria

7. Market Growth Drivers

8. Drivers and their Impact

9. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends


12. Key Vendor Analysis
12.1. Vendor 1
12.1.1. Business Overview
12.1.2. Business Segmentation
12.1.3. Key Information
12.1.4. SWOT Analysis
12.2. Vendor 2
12.2.1. Business Overview
12.2.2. Business Segmentation
12.2.3. Key Information
12.2.4. SWOT Analysis
12.3. Vendor 3
12.3.1. Business Overview
12.3.2. Business Segmentation
12.3.3. Key Information
12.3.4. SWOT Analysis
12.4. Vendor 4
12.4.1. Business Overview
12.4.2. Business Segmentation
12.4.3. Key Information
12.4.4. SWOT Analysis

13. Other Reports in this Series


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948 

Thursday, 1 August 2013

Just Releases Research : Global Construction Aggregates Market - Key Trends and Opportunities to 2017

Synopsis

This report provides detailed market analysis, information, trends, issues and insights 
into the global constructionaggregates market, including:

  • The regional and global construction aggregates market's growth prospects by category
  • Analysis of the Asia-Pacific, Middle East, North America, Latin America and European markets separately with country level data
  • Critical insight into the impact of the market through comparative analysis of country level data
  • Company profiles of key companies operating in the construction aggregates industry



Now Available : China Rare Earth Permanent Magnet Industry Report, 2012-2015

Amid the global economic downturn and the falling prices of upstream rare earth raw materials and NdFeB products, the demand for downstream NdFeB dropped dramatically in 2012. China’s NdFeB apparent consumption will rebound stably in the wake of the recovered demand in consumer electronics, automotive motors and other major downstream industries since 2013.




China Rare Earth Permanent MagnetIndustry Report, 2012-2015 analyzes the global and Chinese rare earth permanent magnet markets as well as forecasts development trends from the angles of rare earth raw material supply, rare earth permanent magnet supply and demand, market prices and major production enterprises.

In H1 2012, the operating rate of China NdFeB industry was less than 50%. High-end NdFeB manufacturers maintained the operating rate as high as 70%-75%, while low-end NdFeB companies only saw 30%-40%. Since 2013, downstream industries have transferred from “de-stocking” to “re-stocking”, which stimulated the growth in orders for NdFeB and boosted the industrial operating rate obviously. In Q2 2013, the operating rate of major Chinese NdFeB producers returned to 70-80%.

By 2014 when the patent licenses of Japanese Sumitomo and U.S. Magnequench will expire in European, American and Japanese NdFeB markets, Chinese NdFeB enterprises will witness breakthroughs in export, but eight of them who hold export patent licenses (including Zhong Ke San Huan and Ningbo Yunsheng) will also face fierce competition herein.



Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Research Report on Global and China Monoclonal Antibody Industry, 2013-2017

Antibody drugs are usually generated from monoclonal antibody through genetic engineering, with the advantages of strong targeting, few side effects, etc. With rather promising application prospect in clinic treatment, antibody drugs are mainly applied in curing diseases like tumour, immune system and so on. In terms of the global market, antibody drugs account for over 40% of the entire biotech drug market and the market share still keeps increasing. Antibody drugs have become one of the most important parts of biotech drugs and monoclonal antibody drugs are even star products of antibody drugs. Among the top 10 best selling drugs in 2012, six of them were monoclonal antibody drugs with each annual sales value exceeding USD 5 billion.




In recent years, the market scale of monoclonal antibody drugs increased rapidly. In 2012, the global sales value of monoclonal antibody preparation exceeded USD 50 billion. Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avastin, Herceptin, Rituximab, etc. In 2012, its sales value of monoclonal antibody products reached USD 20 billion. Mono antibody drugs will become the main force promoting the development of biological drugs in the next few years.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172373


In recent years, China bio pharmaceuticals industry develops rapidly, but antibody drugs lag far behind the average international level with sales value being less than 3% of biological drug share. At present, China antibody drug market is still in the initial stage. However, with Shanghai CITIC National Health Pharmaceutical Co., Ltd. and Biotech Pharmaceutical Co., Ltd. releasing humanization products, product types of domestic antibody drugs will enter the upgrading stage. Although domestic full humanization products have not been released, humanization products and full humanization products will become the domestic trend of monoclonal antibody products in the future.


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Challenges and Opportunities in the Renal Denervation Market


Hypertension: Prevalence and Significance

Hypertension is one of the most preventable causes of premature morbidity and mortality globally. It is a major risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, peripheral vascular disease, cognitive decline, damage to retinal blood vessels and visual impairment, and premature death. Therefore, reducing hypertension can lower the incidence of these conditions, helping to improve the health of the population and reducing the high burdens that they place on global healthcare systems.




Renal denervation therapy involves a surgical procedure and is therefore a last resort in the treatment of hypertension. It is only considered when cheaper, simpler and potentially safer alternatives such as lifestyle modifications and the use of pharmaceuticals have failed. These patients are termed as having treatment-resistant hypertension.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172371


Current Trends and Future Opportunities

With renal denervation technology only having been in development since the late 1990s and commercially-available since 2010, the market is in its infancy. The products remain unapproved in the US and Japan, and reimbursement is not yet widely available in other regions. Despite being an emerging market, renal denervation has sparked considerable interest due to the good safety and efficacy results it has achieved so far in helping to reduce treatment-resistant hypertension. The expectation is that renal denervation could become a multi-billion dollar market in the future. However, the success of any new medical technology is dependent on regulatory approval and reimbursement; acceptance and awareness from the medical community; and evidence of safety, efficacy and cost-effectiveness. All of these elements must be in place for the market to realise its potential.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

China High Voltage DC Power Supply Market 2013-2017

With the development of power electronics technology and the emergence of new high-performance, high withstanding voltage and high-frequency power electronic devices, high voltage DC power supply is widely applied in industry, agriculture, health care, defense and scientific research, such as: X-ray tube, bone density testing, analytical instruments, electrophoresis, semiconductors, ion implantation, lithography, non-destructive testing, X-ray imaging, electrostatic dust removal, lampblack purification, electrostatic spraying, CT machines, laser equipment, ozone equipment, etc.




At present, technological gap between domestic high voltage power supply products and that in foreign countries still exist; a large quantity of core devices had to rely on imports so as to guarantee the products quality.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172014


The survey of Huidian Research shows that since 2008, with the widening of the application areas, HVDC power supply showed a rapid growth rate; the average annual growth rate was higher than 60%. Impacted by the macro environment in 2012, the growth speed was slowed down; the sales volume was 160,000 units, up 33% YoY; the sales revenue was CNY 1.8 billion, up 38% YoY. Because the quality of the domestic core devices is relatively poor, a large number of products are imported from foreign counties; the imported products account for about 1/3 of the market share currently. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948